Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04166721
Title WaKING: Wnt and checKpoint INhibition in Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Royal Marsden NHS Foundation Trust
Indications

gastroesophageal adenocarcinoma

Therapies

Atezolizumab + DKN-01

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST